Skip to main content
. Author manuscript; available in PMC: 2014 Apr 2.
Published in final edited form as: Chem Biol. 2008 Aug 25;15(8):854–862. doi: 10.1016/j.chembiol.2008.06.008

Table 2.

Relative Content of NAM-modified, Cysteine-containing Peptides Identified by MS in Tryptic Digest of NAM-treated hMGL

hMGL cysteine residues m/z Relative Alkylation
NAM:hMGL ratio
8.3:1 33:1
Cys39 3144.62; 3300.72 0% 100%(a)
Cys208 2007.05 0% 0%(a)
Cys215 2158.28 26%(b) 22%(b)
Cys249 2445.38; 3534.97 74%(b) 78%(b)
(a)

percent alkylation of Cys39 relative to Cys208

(b)

percent alkylation of Cys215 relative to Cys249

HHS Vulnerability Disclosure